APA (7th ed.) Citation

B, A., KS, A., F, L., AK, A., NA, E., J, S., . . . H, E. (2022). The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: An updated systematic review and meta-analysis of randomized controlled trials. Expert review of anticancer therapy, 22(10), 1127. https://doi.org/10.1080/14737140.2022.2116005

Chicago Style (17th ed.) Citation

B, Abdelazeem, et al. "The Role of Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-line Treatment for Advanced Non-small Cell Lung Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials." Expert Review of Anticancer Therapy 22, no. 10 (2022): 1127. https://doi.org/10.1080/14737140.2022.2116005.

MLA (9th ed.) Citation

B, Abdelazeem, et al. "The Role of Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-line Treatment for Advanced Non-small Cell Lung Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials." Expert Review of Anticancer Therapy, vol. 22, no. 10, 2022, p. 1127, https://doi.org/10.1080/14737140.2022.2116005.